Pharmaceutical / Drug Definition :
Binds to nuclear receptors in responsive tissues (such as female genital organs, breasts, and pituitary gland), enhancing DNA, RNA, and protein synthesis. In androgen-dependent prostate cancer, competes for androgen receptor sites, inhibiting androgen activity. Also decreases pituitary release of follicle-stimulating hormone and luteinizing hormone.
Registrar Corp assists Estradiol companies with:
FDA Registration
Estradiol
FDA Listing
Estradiol
FDA Label Requirements and Exceptions
Estradiol
FDA Import Information
Estradiol
FDA Detentions
Estradiol (Estradiol Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Estradiol (Estradiol Suppliers)
- Processors Estradiol
- Repackers Estradiol
- Relabelers Estradiol
- Exporters Estradiol
- Importers Estradiol
For more information about Estradiol, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
